Don’t miss this historic debate between Children’s Health Defense Chairman Robert F. Kennedy, Jr. and Harvard Law Professor Alan Dershowitz.
With the current COVID crisis dominating headlines at national and local levels, the topic of vaccines is now front and center.
The two attorneys debate a range of issues including vaccine mandates, the PREP Act, the lack of vaccine safety studies, Jacobson vs. Massachusetts, and HHS’s failure to act on provisions of the National Childhood Vaccine Injury Act. Are compulsory vaccines even legal? Should any government be able to force medical procedures on families?
An insightful discussion that no one contemplating vaccine safety should miss.
Note to readers: please click the share buttons above or below. Forward this article to your email lists. Crosspost on your blog site, internet forums. etc.
Featured image is from Natural News
Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Centre of Research on Globalization grants permission to cross-post Global Research articles on community internet sites as long the source and copyright are acknowledged together with a hyperlink to the original Global Research article. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected]
www.globalresearch.ca contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of “fair use” in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than “fair use” you must request permission from the
For media inquiries: [email protected]